ANTIEPILEPTIC POTENTIAL OF FPL 15896AR

被引：0
|
作者：
WATKINS, BE [1 ]
MURRAY, RJ [1 ]
BALESTRA, M [1 ]
PALMER, GC [1 ]
机构：
[1] FISONS PHARMACEUT,ROCHESTER,NY 14603
来源：
FASEB JOURNAL | 1995年 / 9卷 / 03期
关键词：
D O I：
暂无
中图分类号：
Q5 [生物化学]; Q7 [分子生物学];
学科分类号：
071010 ; 081704 ;
摘要：
引用
收藏
页码：A394 / A394
页数：1
相关论文
共 50 条
  • [21] Comparison of the neuroprotective effect of clomethiazole, AR-R15896AR and NXY-059 in a primate model of stroke using histological and behavioural measures
    Marshall, JWB
    Green, AR
    Ridley, RM
    BRAIN RESEARCH, 2003, 972 (1-2) : 119 - 126
  • [22] Viozan® -: AR-C68397AA -: FPL-68397 -: Treatment of COPD
    不详
    DRUGS OF THE FUTURE, 2001, 26 (02) : 207 - 209
  • [23] Treatment of acute ischaemic stroke with the low-affinity, use-dependent NMDA antagonist AR-R15896AR - A safety and tolerability study
    Diener, HC
    AlKhedr, A
    Busse, O
    Hacke, W
    Zingmark, PH
    Jonsson, N
    Basun, H
    JOURNAL OF NEUROLOGY, 2002, 249 (05) : 561 - 568
  • [24] Tolerability of the low-affinity, use-dependent NMDA antagonist AR-R15896AR in stroke patients - A dose-ranging study
    Lees, KR
    Dyker, AG
    Sharma, A
    Ford, GA
    Ardron, ME
    Grosset, DG
    STROKE, 2001, 32 (02) : 466 - 472
  • [25] Fenfluramine as a potential Antiepileptic drug
    Casaer, P
    Boel, M
    EPILEPSIA, 2002, 43 (02) : 205 - 205
  • [26] Role of hyperthermia in the protective action of clomethiazole against MDMA ('ecstasy')-induced neurodegeneration, comparison with the novel NMDA channel blocker AR-R15896AR
    Colado, MI
    Granados, R
    O'Shea, E
    Esteban, B
    Green, AR
    BRITISH JOURNAL OF PHARMACOLOGY, 1998, 124 (03) : 479 - 484
  • [27] The clinical potential of antiepileptic gene therapy
    McCown, TJ
    EXPERT OPINION ON BIOLOGICAL THERAPY, 2004, 4 (11) : 1771 - 1776
  • [28] Retigabine: the newer potential antiepileptic drug
    Piotr Czuczwar
    Agnieszka Wojtak
    Anna Cioczek-Czuczwar
    Jolanta Parada-Turska
    Ryszard Maciejewski
    Stanistaw J. Czuczwar
    Pharmacological Reports, 2010, 62 : 211 - 219
  • [29] PROBLEMS IN THE ASSESSMENT OF POTENTIAL ANTIEPILEPTIC DRUGS
    EADIE, MJ
    CNS DRUGS, 1994, 1 (03) : 167 - 171
  • [30] Teratogenicity and antiepileptic drugs: Potential mechanisms
    Yerby, Mark S.
    EPILEPSY IN WOMEN: THE SCIENTIFIC BASIS FOR CLINICAL MANAGEMENT, 2008, 83 : 181 - 204
12345